| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -3% |
| 3Y CAGR | -5% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -24% |
| 3Y CAGR | -5% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹3,743.70 -65.00 (1.71%) | 17,417.08 | 23.69 | 4.14 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,218.30 -40.50 (1.79%) | 17,194.23 | 25.36 | 5.1 | ||
Natco PharmaNATCOPHARM | ₹781.55 -19.30 (2.41%) | 15,708.15 | 13.72 | 1.5 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,026.00 -13.50 (0.22%) | 15,108.25 | 89.07 | 17.31 |